Resources

Transactions

Pfizer Sells Consumer Healthcare Business to Johnson & Johnson for US$16.6 Billion

Published: 12/20/2006

By Stuart English, Yana Ermak, Tom Kapsales, Bernice Karn, Emily Larose, Andrew M. Reback, Gary Steinhart

On December 20, 2006, Pfizer Inc. completed the sale of its Consumer Healthcare Business to Johnson & Johnson for US$16.6 billion.

Cassels Brock represented Pfizer in Canada.